212 related articles for article (PubMed ID: 11431360)
21. Deletion of C-MYC in the spectrum of transformed follicular lymphoma grade 3b.
Tzankov A; Höllrigl A; Verdorfer I; Oxle H
Hum Pathol; 2007 Jan; 38(1):191-2; author reply 192-3. PubMed ID: 17169631
[No Abstract] [Full Text] [Related]
22. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
[TBL] [Abstract][Full Text] [Related]
23. Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression.
Heckman CA; Duan H; Garcia PB; Boxer LM
Oncogene; 2006 Feb; 25(6):888-98. PubMed ID: 16186795
[TBL] [Abstract][Full Text] [Related]
24. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
[TBL] [Abstract][Full Text] [Related]
25. Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement.
Ouansafi I; He B; Fraser C; Nie K; Mathew S; Bhanji R; Hoda R; Arabadjief M; Knowles D; Cerutti A; Orazi A; Tam W
Am J Clin Pathol; 2010 Dec; 134(6):972-81. PubMed ID: 21088162
[TBL] [Abstract][Full Text] [Related]
26. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
27. Expression of P0- and P3-RNA from the normal and translocated c-myc allele in Burkitt's lymphoma cells.
Eick D; Polack A; Kofler E; Lenoir GM; Rickinson AB; Bornkamm GW
Oncogene; 1990 Sep; 5(9):1397-402. PubMed ID: 2216463
[TBL] [Abstract][Full Text] [Related]
28. A variant translocation t(2;18) in follicular lymphoma involves the 5' end of bcl-2 and Ig kappa light chain gene.
Hillion J; Mecucci C; Aventin A; Leroux D; Wlodarska I; Van Den Berghe H; Larsen CJ
Oncogene; 1991 Jan; 6(1):169-72. PubMed ID: 1899478
[TBL] [Abstract][Full Text] [Related]
29. A human Burkitt's lymphoma cell line carrying t(8;22) and t(14;18) translocations.
Kiefer T; Schüler F; Knopp A; Wimmer M; Hirt C; Schaefer HE; Dölken G
Ann Hematol; 2007 Nov; 86(11):821-30. PubMed ID: 17622530
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
[TBL] [Abstract][Full Text] [Related]
31. The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma.
Peh SC; Shaminie J; Tai YC; Tan J; Gan SS
Histopathology; 2004 Nov; 45(5):501-10. PubMed ID: 15500654
[TBL] [Abstract][Full Text] [Related]
32. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
33. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
[TBL] [Abstract][Full Text] [Related]
34. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
Wilda M; Busch K; Klose I; Keller T; Woessmann W; Kreuder J; Harbott J; Borkhardt A
Genes Chromosomes Cancer; 2004 Oct; 41(2):178-82. PubMed ID: 15287031
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and functional analysis of the promoter region of rat nonmuscle myosin heavy chain-B gene.
Yam JW; Chan KW; Li N; Hsiao WL
Biochem Biophys Res Commun; 2000 Oct; 276(3):1203-9. PubMed ID: 11027611
[TBL] [Abstract][Full Text] [Related]
36. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
37. CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas.
Ji L; Mochon E; Arcinas M; Boxer LM
J Biol Chem; 1996 Sep; 271(37):22687-91. PubMed ID: 8798441
[TBL] [Abstract][Full Text] [Related]
38. Regulation of bcl-2 gene expression in lymphoid cell lines containing normal #18 or t(14;18) chromosomes.
Reed JC; Tsujimoto Y; Epstein SF; Cuddy M; Slabiak T; Nowell PC; Croce CM
Oncogene Res; 1989; 4(4):271-82. PubMed ID: 2771409
[TBL] [Abstract][Full Text] [Related]
39. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
Gerbitz A; Mautner J; Geltinger C; Hörtnagel K; Christoph B; Asenbauer H; Klobeck G; Polack A; Bornkamm GW
Oncogene; 1999 Mar; 18(9):1745-53. PubMed ID: 10208435
[TBL] [Abstract][Full Text] [Related]
40. The role of phosphorylation of DNA-binding proteins in regulation of transcription of the human c-myc gene.
Imamova LR; Chernov BK; Itkes AV
Biochemistry (Mosc); 1997 Oct; 62(10):1152-7. PubMed ID: 9461638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
